An Expanded Access Program for SYN023 in Rabies Treatment

NCT07706907 · clinicaltrials.gov ↗

AVAILABLE

Status

INDUSTRY

Sponsor class

Conditions

Rabies

Interventions

DRUG: Zamerovimab and Mazorelvimab Injection

Sponsor

Synermore Biologics (Suzhou) Co., Ltd.